Source:http://linkedlifedata.com/resource/pubmed/id/10940103
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2000-12-21
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0017-8748
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
40
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
605-9
|
| pubmed:dateRevised |
2009-2-2
|
| pubmed:meshHeading |
pubmed-meshheading:10940103-Data Interpretation, Statistical,
pubmed-meshheading:10940103-Humans,
pubmed-meshheading:10940103-Migraine Disorders,
pubmed-meshheading:10940103-Sumatriptan,
pubmed-meshheading:10940103-Treatment Outcome,
pubmed-meshheading:10940103-Triazoles,
pubmed-meshheading:10940103-Tryptamines
|
| pubmed:articleTitle |
Comparison of rizatriptan and sumatriptan: a reply to Tfelt-Hansen et al.
|
| pubmed:publicationType |
Letter,
Comparative Study,
Comment
|